Start for free
Start for free
ClavystBio logo

ClavystBio

Asia, Central Region, Singapore, Singapore

Description

ClavystBio invest in early-stage ventures in the biotech, medtech and digital health sectors.

Investor Profile

ClavystBio has made 7 investments, with 3 in the past 12 months and 43% as lead.

Stage Focus

  • Series A (57%)
  • Seed (14%)
  • Series Unknown (14%)
  • Series B (14%)

Country Focus

  • Singapore (57%)
  • United States (29%)
  • The Netherlands (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Internet
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ClavystBio frequently co-invest with?

EcoR1 Capital
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Xora Innovation
Xora Innovation
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Seeds Capital
Seeds Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
CV
Coronet Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Accelerator Life Science Partners
Accelerator Life Science Partners
North America, New York, United States, New York
Co-Investments: 1
EDBI
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 4
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
Leaps by Bayer
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 2
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by ClavystBio?

Callio Therapeutics

Seattle, Washington, United States

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

BiotechnologyHealth CareMedical
Series AMar 3, 2025
Amount Raised: $187,000,000
Leyden Labs

Amsterdam, Noord-Holland, The Netherlands

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

BiotechnologyLife ScienceTherapeutics
Series BJan 9, 2025
Amount Raised: $70,000,000
Sunbird Bio

Singapore, Central Region, Singapore

Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series UnknownOct 16, 2024
Amount Raised: $14,000,000
Engine Biosciences

Singapore, Central Region, Singapore

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine Learning
Series AOct 31, 2023
Amount Raised: $27,000,000
65LAB

Singapore, Central Region, Singapore

65LAB focuses on scientific advancement to create new therapeutic companies and lifesaving medicines.

InternetMedical
SeedOct 5, 2023
Automera

Singapore, Central Region, Singapore

Automera focuses on a novel therapeutic methods to develop drugs.

BiotechnologyTherapeutics
Series ASep 27, 2023
Amount Raised: $16,000,000
Paratus Sciences

New York, New York, United States

Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.

BiotechnologyHealth Care
Series AFeb 27, 2023
Amount Raised: $100,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator